📰 Johnc Jacobs News
Page 3 - Johnc Jacobs News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Johnc Jacobs. Real-time updates on events, politics, business and more.
November 28, 2023
Novavax's protein-based vaccine can now be offered to all 194 member nations of the WHO, as well as Unicef and other agencies.
November 28, 2023
/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that Nuvaxovid™...
November 17, 2023
New organizational structure for executive leadership team designed to facilitate a leaner and more focused approach to annual execution of business plansJohn Trizzino appointed to new Chief...
November 10, 2023
GAITHERSBURG, Md., Nov. 10, 2023 /PRNewswire/ -- Novavax, Inc. , a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that it will participate in the...
November 9, 2023
Received authorization from the U.S. FDA and approval from the European Commission for the Companys updated COVID-19 vaccine, and launched the only...
November 1, 2023
Novavaxs updated COVID-19 vaccine is the only updated protein-based non-mRNA COVID-19 vaccine available in the European Union for individuals aged 12 and olderNovavax is working closely with EU...
October 31, 2023
/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that the...
October 31, 2023
/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced the European...
October 18, 2023
(2023-10-18 | NDAQ:NVAX) Novavax's Prototype COVID-19 Vaccine Nuvaxovid(TM) Receives Full Approval in Singapore
October 18, 2023
GAITHERSBURG, Md., Oct. 18, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M...